Risk Factors for In-Hospital Mortality among Patients with Coronavirus-19 in Isfahan City, Iran

Roya Riahi1, Marziye Ghasemi2, Zahra Montazeri Shatouri3

  • 1Department of Biostatistics and Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Older age, COPD history, high white blood cell counts, low hemoglobin, bilateral pulmonary infiltrates, ARDS, and ICU admission are key risk factors for COVID-19 mortality in hospitalized patients.

Area of Science:

  • Epidemiology
  • Clinical Medicine
  • Infectious Diseases

Background:

  • The COVID-19 pandemic has led to significant in-hospital mortality.
  • Identifying risk factors for mortality is crucial for patient management and resource allocation.

Purpose of the Study:

  • To investigate the risk factors associated with mortality among hospitalized COVID-19 patients in Isfahan province.
  • To provide data that can inform clinical decision-making and public health strategies.

Main Methods:

  • Retrospective cohort study of 1044 COVID-19 patients admitted to three hospitals in Isfahan province.
  • Data extracted from medical records included demographics, clinical, laboratory, and outcome information.
  • Analysis focused on identifying factors predicting in-hospital mortality.

Main Results:

  • Older age (≥65 years), history of chronic obstructive pulmonary disease (COPD), elevated white blood cell (WBC) counts, and low hemoglobin (Hb) levels were significant risk factors.
  • Bilateral pulmonary infiltrates on admission, development of acute respiratory distress syndrome (ARDS), and intensive care unit (ICU) admission also increased mortality risk.
  • Adjusted hazard ratios (aHR) and 95% confidence intervals (CI) were calculated for each identified risk factor.

Conclusions:

  • Several factors, including older age, pre-existing conditions like COPD, specific laboratory findings (WBC, Hb), and disease severity indicators (pulmonary infiltrates, ARDS, ICU admission), are linked to higher mortality in COVID-19 patients.
  • These findings underscore the importance of close monitoring and tailored interventions for high-risk individuals.
  • Further research is recommended to explore these risk factors more deeply.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
312
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
274
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
251
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
178
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13